FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

René van der Griend

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Antineoplastic Combined Chemotherapy Protocols

Co-author Network

Publications

TOP 3
Patricia A H Hamers; S F T Thijsen; René van der Griend; Lenneke E M Haas
An ICU patient with spots and a peculiar pneumonia.
Silvia G R Verelst; Pierre W Wijermans; Shulamiet Wittebol; Sonja Zweegman; A H M Ammerlaan; Henk M Lokhorst; M Ronald Schaafsma; H A M Sinnige; Pieter Sonneveld; Fabian Termorshuizen; Carin A Uyl-de Groot; René van der Griend; Marinus van Marwijk Kooy
Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial.
M J Agterof; R E G Schutgens; J F Verzijlbergen; M M C van Buul; E A M Tromp; M J C Eijkemans; René van der Griend; Douwe H Biesma
No firm association between N-terminal pro-brain natriuretic peptide and percentage of pulmonary vascular obstruction in patients with acute pulmonary embolism.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of René van der Griend (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Patricia A H Hamers; S F T Thijsen; René van der Griend; Lenneke E M Haas
An ICU patient with spots and a peculiar pneumonia.
BMJ case reports 2013;2013():.
2011: Silvia G R Verelst; Pierre W Wijermans; Shulamiet Wittebol; Sonja Zweegman; A H M Ammerlaan; Henk M Lokhorst; M Ronald Schaafsma; H A M Sinnige; Pieter Sonneveld; Fabian Termorshuizen; Carin A Uyl-de Groot; René van der Griend; Marinus van Marwijk Kooy
Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial.
Annals of hematology 2011;90(12):1427-39.
2011: M J Agterof; R E G Schutgens; J F Verzijlbergen; M M C van Buul; E A M Tromp; M J C Eijkemans; René van der Griend; Douwe H Biesma
No firm association between N-terminal pro-brain natriuretic peptide and percentage of pulmonary vascular obstruction in patients with acute pulmonary embolism.
Thrombosis research 2011;127(6):547-50.
2011: F F Van Doormaal; W Terpstra; René van der Griend; Martin H Prins; Marten Nijziel; Marcel A van de Ree; Harry R Büller; J C Dutilh; A ten Cate-Hoek; S M Van Den Heiligenberg; Jan van der Meer; J M Otten
Is extensive screening for cancer in idiopathic venous thromboembolism warranted?
Journal of thrombosis and haemostasis : JTH 2011;9(1):79-84.
2010: Esther R van Bladel; Mariëtte J Agterof; Bernard D Frijling; René van der Griend; Martin H Prins; Roger Schutgens; Douwe H Biesma
Out of hospital anticoagulant therapy in patients with acute pulmonary embolism is frequently practised but not perfect.
Thrombosis research 2010;126(6):481-5.
2010: Pierre W Wijermans; Martijn Schaafsma; Fabian Termorshuizen; Rianne Ammerlaan; Shulamiet Wittebol; Harm Sinnige; Sonja Zweegman; Marinus van Marwijk Kooy; René van der Griend; Henk M Lokhorst; Pieter Sonneveld
Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(19):3160-6.
2010: M J Agterof; Roger Schutgens; Repke J Snijder; G Epping; H G Peltenburg; E F M Posthuma; J A Hardeman; René van der Griend; T Koster; Martin H Prins; Douwe H Biesma
Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level.
Journal of thrombosis and haemostasis : JTH 2010;8(6):1235-41.
2008: Ellen van der Spek; René van der Griend
Comment to: Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Haematologica 2008; 93:398-403.
Haematologica 2008;93(7):e57; author reply e58.
2008: Annemarie C Venhuizen; Willem N M Hustinx; Arend-Jan van Houte; Gerda Veth; René van der Griend
Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma.
European journal of haematology 2008;80(3):275-6.
2007: Ankie M T van der Velden; Heleen van Velzen-Blad; A M E Claessen; René van der Griend; Ruud Oltmans; Ger T Rijkers; Douwe H Biesma
The effect of ranitidine on antibody responses to polysaccharide vaccines in patients with B-cell chronic lymphocytic leukaemia.
European journal of haematology 2007;79(1):47-52.
2006: Ellen van der Spek; Andries C Bloem; Niels W C J van de Donk; Lijnie H Bogers; René van der Griend; Mark H H Kramer; Okke de Weerdt; Shulamiet Wittebol; Henk M Lokhorst
Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma.
Haematologica 2006;91(4):542-5.
2005: Bas Oldenburg; Bas A C Van Tuyl; René van der Griend; Rob Fijnheer; Gerard P van Berge-Henegouwen
Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia.
Digestive diseases and sciences 2005;50(2):235-40.
2003: Marielle F van de Laak; Diederick Grobbee; René van der Griend; Harold W de Valk; Ale Algra; Jan-Dirk Banga; Yolanda van der Graaf
A 2-step strategy to reduce the need for methionine-loading tests to diagnose hyperhomocysteinemia.
The Journal of laboratory and clinical medicine 2003;142(2):121-7.
2002: René van der Griend; Douwe H Biesma; Jan-Dirk Banga
Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens.
Vascular medicine (London, England) 2002;7(1):29-33.
2000: René van der Griend; Douwe H Biesma; Jan-Dirk Banga
Clinical relevance of the methionine loading test for assessment of hyperhomocysteinaemia.
The Netherlands journal of medicine 2000;57(4):174-5.
2000: Bas Oldenburg; Rob Fijnheer; René van der Griend; Gerard P vanBerge-Henegouwen; JC Koningsberger
Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
The American journal of gastroenterology 2000;95(10):2825-30.
2000: René van der Griend; Douwe H Biesma; Fred J L M Haas; J A Faber; M Duran; OJ Meuwissen; Jan-Dirk Banga
The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations.
Journal of internal medicine 2000;248(3):223-9.
2000: René van der Griend; Douwe H Biesma; Jan-Dirk Banga
Hyperhomocysteinaemia as a cardiovascular risk factor: an update.
The Netherlands journal of medicine 2000;56(3):119-30.
1999: René van der Griend; Fred J L M Haas; Douwe H Biesma; M Duran; OJ Meuwissen; Jan-Dirk Banga
Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives.
Atherosclerosis 1999;143(1):177-83.
1999: René van der Griend; Leo F Verdonck; Eefke J Petersen; P Veenhuizen; Andries C Bloem; Henk M Lokhorst
Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation.
Bone marrow transplantation 1999;23(2):195-7.
1998: René van der Griend; Fred J L M Haas; M Duran; Douwe H Biesma; OJ Meuwissen; Jan-Dirk Banga
Methionine loading test is necessary for detection of hyperhomocysteinemia.
The Journal of laboratory and clinical medicine 1998;132(1):67-72.
1996: H W de Valk; M K van Eeden; J D Banga; René van der Griend; E de Groot; F J Haas; O J Meuwissen; M Duran; Jan A M Smeitink; B T Poll-The; J B de Klerk; D Wittebol-Post; M O Rolland
Evaluation of the presence of premature atherosclerosis in adults with heterozygosity for cystathionine-beta-synthase deficiency.
Stroke; a journal of cerebral circulation 1996;27(6):1134-6.
1996: Henk M Lokhorst; Pieter Sonneveld; Pierre W Wijermans; Marinus van Marwijk Kooy; O J Meuwissen; R H van Oers; René van der Griend; Adriaan W Dekker
Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma.
British journal of haematology 1996;92(1):44-8.
1994: René van der Griend; O J Meuwissen
[Hyperhomocysteinemia as risk factor for premature atherosclerosis].
Nederlands tijdschrift voor geneeskunde 1994;138(9):456-9.